Literature DB >> 25211741

Politics, profit, and psychiatric diagnosis: a case study of tobacco use disorder.

Laura D Hirshbein1.   

Abstract

The idea of tobacco or nicotine dependence as a specific psychiatric diagnosis appeared in 1980 and has evolved through successive editions of the American Psychiatric Association's Diagnostic and Statistical Manual. Not surprisingly, the tobacco industry attempted to challenge this diagnosis through behind-the-scenes influence. But another entity put corporate muscle into supporting the diagnosis-the pharmaceutical industry. Psychiatry's ongoing professional challenges have left it vulnerable to multiple professional, social, and commercial forces. The example of tobacco use disorder illustrates that mental health concepts used to develop public health goals and policy need to be critically assessed. I review the conflicting commercial, professional, and political aims that helped to construct psychiatric diagnoses relating to smoking. This history suggests that a diagnosis regarding tobacco has as much to do with social and cultural circumstances as it does with science.

Entities:  

Mesh:

Year:  2014        PMID: 25211741      PMCID: PMC4202992          DOI: 10.2105/AJPH.2014.302125

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  Conversation with Murray Jarvik.

Authors:  M Jarvik
Journal:  Addiction       Date:  2001-09       Impact factor: 6.526

2.  Inventing conflicts of interest: a history of tobacco industry tactics.

Authors:  Allan M Brandt
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

3.  Cigarette smoking as an addiction.

Authors:  J H Jaffe
Journal:  Am Lung Assoc Bull       Date:  1976-05

Review 4.  DSM-III and the transformation of American psychiatry: a history.

Authors:  M Wilson
Journal:  Am J Psychiatry       Date:  1993-03       Impact factor: 18.112

5.  Edited correspondence on the status of homosexuality in DSM-III.

Authors:  R Bayer; R L Spitzer
Journal:  J Hist Behav Sci       Date:  1982-01

6.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

7.  Scientific research and corporate influence: smoking, mental illness, and the tobacco industry.

Authors:  Laura Hirshbein
Journal:  J Hist Med Allied Sci       Date:  2011-05-19       Impact factor: 2.088

8.  DSM-III and the revolution in the classification of mental illness.

Authors:  Rick Mayes; Allan V Horwitz
Journal:  J Hist Behav Sci       Date:  2005

9.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

10.  Neurosis, psychodynamics, and DSM-III. A history of the controversy.

Authors:  R Bayer; R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1985-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.